AliveDx Suisse SA Austria Belgium France Germany Italy Netherlands Spain Switzerland United Kingdom United States of America

26.08.2025 - 15:01:15

AliveDx registers MosaiQ®, its Instrument for Multiplex Testing of Autoimmune Diseases, Allergies and Beyond, as a Class II Exempt Device with the U.S. Food and Drug Administration

and connect with us on LinkedIn and X.?

©AliveDx Suisse SA. 2025. The AliveDx logo, AliveDx, MosaiQ ?AiPlex and AllergyPlex are trademarks or registered trademarks of AliveDx group companies in various jurisdictions. Menus and capabilities are subject to change. Not all methods may be available in all territories. Subject to regulatory clearance.

Logo - https://mma.prnewswire.com/media/2657402/5476988/AliveDx_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/alivedx-registers-mosaiq-its-instrument-for-multiplex-testing-of-autoimmune-diseases-allergies-and-beyond-as-a-class-ii-exempt-device-with-the-us-food-and-drug-administration-fda-302538728.html